Sort
172,184 grants matching “inflammation”
Role of spleen educated monocytes in mediating ischemia-reperfusion injury followinglung transplant surgery
$773,403Ankit Bharat · Northwestern University At Chicago · R01 · FY2025 · HL
The role of pathogen-experienced macrophage subsets in mediating lung immunity and heterologous protection
$773,368Amariliz Rivera · Rutgers Biomedical And Health Sciences · R01 · FY2024 · AI
Enhancing cardiovascular risk prediction in HIV using novel factors in the REPRIEVE trial
$773,364Virginia Athena Triant · Massachusetts General Hospital · R01 · FY2024 · HL
Understanding the Cardiac Benefits of Exercise at the Cellular and Molecular Level
$773,364Anthony Rosenzweig · University Of Michigan At Ann Arbor · R35 · FY2025 · HL
Leukocyte Telomere Length and Cardiovascular Disease in Jackson Heart Study
$773,363Alexander P Reiner · Fred Hutchinson Cancer Research Center · R01 · FY2014 · HL
The impact of prenatal maternal infection and inflammation on human brain development and psychopathology during adolescence
$773,290Veerle Bergink · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · MH
Confirmatory Double-Blind Placebo-Controlled Efficacy Trial of a Gluten-Free Diet in a Subgroup of Persons with Schizophrenia Who Have High Levels of IgG Anti-Gliadin Antibodies
$773,272Deanna L Kelly · University Of Maryland Baltimore · R01 · FY2021 · MH
Membrane cholesterol and vascular inflammation
$773,259Peter J Tontonoz · University Of California Los Angeles · R01 · FY2025 · HL
Psychosocial Stress due to COVID-19 and Vascular Aging in African-American Women
$773,251Tenã T Lewis · Emory University · R01 · FY2021 · HL
CHEMICAL SCREENING AND OPTIMIZATION FACILITY - SCALABLE QUANTITIES
$773,237Leyi Gong · Sri International · N01 · FY2023 · HD
Mechanisms of autoimmune disease risk in IL2/IL2RA-dependent immune tolerance
$773,229Andrew D Wells · Children'S Hosp Of Philadelphia · R01 · FY2021 · AI
Viral Triggers of Alloimmunity and Autoimmunity in Pediatric Lung Transplantation
$773,189Stuart C Sweet · Washington University · U01 · FY2012 · AI
An additive solution optimized for anaerobic (hypoxic) RBC storage to minimize storage lesion development.
$773,178Tatsuro Yoshida · New Health Sciences, Inc. · R44 · FY2021 · HL
The Role of Iron in the Pathogenesis of NAFLD
$773,137Kris Kowdley · Benaroya Research Inst At Virginia Mason · R01 · FY2011 · DK
Anti-interneuron antibodies in rapid-onset pediatric OCD: clinical generalization and target identification
$773,117Christopher John Pittenger · Yale University · R01 · FY2025 · MH
Midwest Sickle Cell Center (MSCC)
$773,102Cheryl A Hillery · Medical College Of Wisconsin · U54 · FY2009 · HL
PTSD and Ischemic Heart Disease Progression: A Longitudinal Twin Study
$773,058Viola Vaccarino Vaccarino · Emory University · R01 · FY2015 · HL
Project 2: Delineating virus and host cell-derived biomarkers predicting time to HIV rebound after treatment interruption
$773,034Warner C Greene · J. David Gladstone Institutes · P01 · FY2019 · AI
Chronic Moderate Sleep Restriction in Older Long and Older Average Sleepers
$773,032Shawn D Youngstedt · Arizona State University-Tempe Campus · R01 · FY2014 · HL
Persistent H. influenzae in COPD - virulence, vaccines and antibiotic resistance
$772,946Timothy F Murphy · State University Of New York At Buffalo · R01 · FY2015 · AI
Washington University Rheumatic DiseasesResearch Resource-based Center
$772,944Christine T Pham · Washington University · P30 · FY2019 · AR
An autoimmune center of excellence for the study of IgG4-related disease
$772,936Shiv Subramaniam Pillai · Massachusetts General Hospital · U19 · FY2025 · AI
Epithelium-derived alarmins role in breast cancer immunoprevention
$772,892Shadmehr Demehri · Massachusetts General Hospital · U01 · FY2020 · CA
3D-bioprinting of sustained- and phased-release antibiotic and probiotic scaffolds to treat bacterial vaginosis
$772,879Hermann Frieboes · University Of Louisville · R01 · FY2022 · AI
Collision of Alzheimers disease and COVID-19 pandemic in the United States: risks, outcomes, disparities and treatments
$772,838Rong Xu · Case Western Reserve University · R01 · FY2025 · AG